About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

ReproCELL Incorporated(4978) Summary

4978
TSE Growth
ReproCELL Incorporated
132
JPY
-7
(-5.04%)
Apr 4, 3:30 pm JST
0.90
USD
Apr 4, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
1.41
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 4, 2025
Opening Apr 4, 9:00 am
136 JPY 0.92 USD
Previous Close Apr 3
139 JPY 0.94 USD
High Apr 4, 9:01 am
139 JPY 0.95 USD
Low Apr 4, 1:54 pm
127 JPY 0.87 USD
Volume
2,041,000
Trading Value
0.27B JPY 1.85M USD
VWAP
132.53 JPY 0.91 USD
Minimum Trading Value
13,200 JPY 90 USD
Market Cap
0.01T JPY 0.09B USD
Number of Trades
1,235
Liquidity & Number of Trades
As of Apr 4, 2025
Liquidity
Slightly High
1-Year Average
696
1-Year High Feb 6, 2025
31,812
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 28, 2025 0 5,208,000
Mar 21, 2025 0 5,562,200
Mar 14, 2025 0 5,152,300
Mar 7, 2025 0 5,074,000
Feb 28, 2025 21,600 5,180,800 239.85
Company Profile
ReproCELL Incorporated is a biotech venture company specializing in iPS cell-related research reagents, collaborating with the University of Tokyo and Kyoto University. The company also offers contract manufacturing services.
Sector
Chemicals
ReproCELL Incorporated develops businesses centered on iPS cell-related technologies. In its research support division, the company manufactures and sells research products, provides research outsourcing services, and distributes cell measurement equipment. The medical division focuses on regenerative medicine research and development, contract manufacturing of iPS cell regenerative medicine products, and clinical testing services. Currently, ReproCELL is developing three regenerative medicine products: StemCaimal, iPS neural glial cells, and tumor-infiltrating lymphocyte infusion therapy. The company's strength lies in its RNA reprogramming technology, which enables the creation of highly safe iPS cells.